Target intelligence / Profile preview

FSHD region gene 2 family member E, pseudogene (FRG2EP)

Target
FRG2EP
Molecular classification
Other (Pseudogene)
01

Overview

FRG2EP (FSHD region gene 2 family member E, pseudogene) is a pseudogene located in the FSHD region of the genome. While some FRG2 family members are candidate genes implicated in FSHD—where changes in transcription may play a role in this muscular dystrophy—FRG2EP itself is nonfunctional and does not code a protein product[3][7]. It is currently not attributed any direct biological function, nor is it recognized as a therapeutic or diagnostic target. There is no evidence that FRG2EP interacts with known drugs or is directly implicated in disease pathogenesis. Some sources ambiguously describe possible regulatory roles for FRG2 family genes in immune response or myogenesis[1][5], but these refer to protein-coding homologues (such as FRG2 or FRG2B), not the FRG2EP pseudogene. There is no reliable evidence that FRG2EP exerts any functional regulatory effect in human physiology[3][7]. Any conflicting or speculative statements about function (such as described as an "inflammasome regulator"[5]) are not supported in authoritative gene databases and should be treated with caution because these attributions are likely confused with other FRG2 family paralogs and not FRG2EP specifically.

02

Biological functions

No demonstrated biological function for FRG2EP itself, as it is a pseudogene, and there is no evidence of translation into a functional protein[3][7].
03

Disease associations

Other (No direct disease causation or marker status attributed to FRG2EP; other functional FRG2 family genes are investigated in FSHD[1], but not FRG2EP itself.)
04

Safety considerations

none reported; as a pseudogene, it is not a target for drugs

Beyond the preview

Go deeper on FSHD region gene 2 family member E, pseudogene (FRG2EP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FSHD region gene 2 family member E, pseudogene (FRG2EP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call